Exane BNP Paribas downgraded Novartis (NYSE: NVS) from Neutral to Underperform.The analyst comments (emphasis ours) "Taking stock of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE